ELVN
Price
$20.67
Change
-$0.85 (-3.95%)
Updated
Jun 27 closing price
Capitalization
1.22B
39 days until earnings call
LQDA
Price
$13.10
Change
+$0.27 (+2.10%)
Updated
Jun 27 closing price
Capitalization
1.12B
39 days until earnings call
Interact to see
Advertisement

ELVN vs LQDA

Header iconELVN vs LQDA Comparison
Open Charts ELVN vs LQDABanner chart's image
Enliven Therapeutics
Price$20.67
Change-$0.85 (-3.95%)
Volume$1.44M
Capitalization1.22B
Liquidia
Price$13.10
Change+$0.27 (+2.10%)
Volume$2.09M
Capitalization1.12B
ELVN vs LQDA Comparison Chart in %
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. LQDA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and LQDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ELVN: $20.67 vs. LQDA: $13.10)
Brand notoriety: ELVN and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 291% vs. LQDA: 91%
Market capitalization -- ELVN: $1.22B vs. LQDA: $1.12B
ELVN [@Biotechnology] is valued at $1.22B. LQDA’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileLQDA’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • LQDA’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than LQDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 5 TA indicator(s) are bullish while LQDA’s TA Score has 1 bullish TA indicator(s).

  • ELVN’s TA Score: 5 bullish, 5 bearish.
  • LQDA’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than LQDA.

Price Growth

ELVN (@Biotechnology) experienced а -2.96% price change this week, while LQDA (@Biotechnology) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

LQDA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.22B) has a higher market cap than LQDA($1.12B). LQDA YTD gains are higher at: 11.395 vs. ELVN (-8.133). ELVN has higher annual earnings (EBITDA): -109.95M vs. LQDA (-122.53M). ELVN has more cash in the bank: 290M vs. LQDA (170M). ELVN has less debt than LQDA: ELVN (365K) vs LQDA (148M). LQDA has higher revenues than ELVN: LQDA (14.1M) vs ELVN (0).
ELVNLQDAELVN / LQDA
Capitalization1.22B1.12B109%
EBITDA-109.95M-122.53M90%
Gain YTD-8.13311.395-71%
P/E RatioN/AN/A-
Revenue014.1M-
Total Cash290M170M171%
Total Debt365K148M0%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNLQDA
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWGGX12.050.09
+0.75%
American Century Focused Global Gr Inv
JGISX88.840.64
+0.73%
JPMorgan U.S. GARP Equity R6
DNFGX43.670.18
+0.41%
Dunham Focused Large Cap Growth N
SHEAX9.350.02
+0.21%
American Beacon Shapiro SMID Cap Eq A
CREFX17.760.03
+0.17%
Cohen & Steers Real Estate Securities F

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-3.95%
ERAS - ELVN
50%
Loosely correlated
N/A
DNLI - ELVN
48%
Loosely correlated
-2.69%
APGE - ELVN
47%
Loosely correlated
N/A
SYRE - ELVN
47%
Loosely correlated
-4.99%
COGT - ELVN
46%
Loosely correlated
-3.14%
More

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+2.10%
MTVA - LQDA
44%
Loosely correlated
-7.35%
KYMR - LQDA
28%
Poorly correlated
-3.48%
ELVN - LQDA
27%
Poorly correlated
-3.95%
FOLD - LQDA
27%
Poorly correlated
N/A
BPMC - LQDA
27%
Poorly correlated
-0.03%
More